Clinical Trial Update: VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates VIC-1911 as a monotherapy and in combination with Sotorasib for KRAS G12C-mutant non-small cell lung cancer. The trial was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• VIC-1911
• sotorasib (sotorasib)

Snippet

Sponsor: Vitrac Therapeutics, LLC | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: TERMINATED | Results posted: 2025-05-01